FERMT1 and neoplasm: In addition, we assessed the expression of molecules such as ANKRD22, GINS3, POLE2, PLEK2, FERMT1 and METTL14 in subcutaneous tumours (Figure S11A) and lung metastatic tissues (Figure S11B).